Carbogen Amcis appoints Stephan Fritschi as CEO
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
Konieczny has served as Interim CEO since April 2024
e brings over 27+ years of rich pharmaceutical experience
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
Subscribe To Our Newsletter & Stay Updated